Applications of Nanotechnology-based Approaches to Overcome Multi-drug Resistance in Cancer

被引:9
作者
Kalave, Sana [1 ]
Hegde, Namita [1 ]
Juvale, Kapil [1 ]
机构
[1] SVKMs NMIMS, Shobhaben Pratapbhai Patel Sch Pharm & Technol Man, VL Mehta Rd,Vile Parle W, Mumbai, India
关键词
MDR; ABC transporters; nanotechnology; nanocarriers; multidrug resistance; cancer; MULTIWALLED CARBON NANOTUBES; POLYMERIC MICELLES; DRUG-RESISTANCE; PROTEIN BCRP/ABCG2; ANTICANCER DRUGS; QUANTUM DOTS; DELIVERY; DOXORUBICIN; PACLITAXEL; NANOCAPSULES;
D O I
10.2174/1381612828666220401142300
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cancer is one of the leading causes of death worldwide. Chemotherapy and radiation therapy are the major treatments used for the management of cancer. Multidrug resistance (MDR) is a major hindrance faced in the treatment of cancer and is also responsible for cancer relapse. To date, several studies have been carried out on strategies to overcome or reverse MDR in cancer. Unfortunately, the MDR reversing agents have been proven to have minimal clinical benefits, and eventually, no improvement has been made in therapeutic efficacy to date. Thus, several investigational studies have also focused on overcoming drug resistance rather than reversing the MDR. In this review, we focus primarily on nanoformulations regarded as a novel approach to overcome or bypass the MDR in cancer. The nanoformulation systems serve as an attractive strategy as these nano-sized materials selectively get accumulated in tumor tissues, thereby improving the clinical outcomes of patients suffering from MDR cancer. In the current work, we present an overview of recent trends in the application of various nano-formulations, belonging to different mechanistic classes and functionalization like carbon nanotubes, carbon nanohorns, carbon nanospheres, liposomes, dendrimers, etc., to overcome MDR in cancer. A detailed overview of these techniques will help researchers in exploring the applicability of nanotechnology-based approaches to treat MDR.
引用
收藏
页码:3140 / 3157
页数:18
相关论文
共 110 条
[1]   Enhancement of In Vivo Anticancer Effects of Cisplatin by Incorporation Inside Single-Wall Carbon Nanohorns [J].
Ajima, Kumiko ;
Murakami, Tatsuya ;
Mizoguchi, Yoshikazu ;
Tsuchida, Kunihiro ;
Ichihashi, Toshinari ;
Iijima, Sumio ;
Yudasaka, Masako .
ACS NANO, 2008, 2 (10) :2057-2064
[2]  
Anitha P., 2018, International Journal of Applied Pharmaceutics, V10, P34, DOI [DOI 10.22159/IJAP.2018V10I5.27075, 10.22159/ijap.2018v10i5.27075]
[3]   Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies [J].
Anwar, Mohammed ;
Akhter, Sohail ;
Mallick, Neha ;
Mohapatra, Sharmistha ;
Zafar, Sobiya ;
Rizvi, M. Moshahid A. ;
Ali, Asgar ;
Ahmada, Farhan J. .
PHARMACOLOGICAL RESEARCH, 2016, 113 :146-165
[4]   Up-regulation and Cytoprotective Role of Epithelial Multidrug Resistance-associated Protein 1 in Inflammatory Bowel Disease [J].
Blokzijl, Hans ;
Van Steenpaal, Axel ;
Borght, Sara Vander ;
Bok, Lisette I. H. ;
Libbrecht, Louis ;
Tamminga, Marieke ;
Geuken, Mariska ;
Roskams, Tania A. D. ;
Dijkstra, Gerard ;
Moshage, Han ;
Jansen, Peter L. M. ;
Faber, Klaas Nico .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (51) :35630-35637
[5]   Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance [J].
Braunova, Alena ;
Kostka, Libor ;
Sivak, Ladislav ;
Cuchalova, Lucie ;
Hvezdova, Zuzana ;
Laga, Richard ;
Filippov, Sergey ;
Cernoch, Peter ;
Pechar, Michal ;
Janouskova, Olga ;
Sirova, Milada ;
Etrych, Tomas .
JOURNAL OF CONTROLLED RELEASE, 2017, 245 :41-51
[6]   Comparison of Cytotoxicity Evaluation of Anticancer Drugs between Real-Time Cell Analysis and CCK-8 Method [J].
Cai, Ling ;
Qin, Xijiang ;
Xu, Zhihui ;
Song, Yiyan ;
Jiang, Huijun ;
Wu, Yuan ;
Ruan, Hongjie ;
Chen, Jin .
ACS OMEGA, 2019, 4 (07) :12036-12042
[7]   Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1) [J].
Chearwae, W ;
Wu, CP ;
Chu, HY ;
Lee, TR ;
Ambudkar, SV ;
Limtrakul, P .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (03) :376-388
[8]   Inorganic Nanoparticle-Based Drug Codelivery Nanosystems To Overcome the Multidrug Resistance of Cancer Cells [J].
Chen, Yu ;
Chen, Hangrong ;
Shi, Jianlin .
MOLECULAR PHARMACEUTICS, 2014, 11 (08) :2495-2510
[9]   ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal [J].
Choi, Cheol-Hee .
CANCER CELL INTERNATIONAL, 2005, 5 (1)
[10]   Rising horizon in circumventing multidrug resistance in chemotherapy with nanotechnology [J].
Choudhury, Hira ;
Pandey, Manisha ;
Yin, Tan Hui ;
Kaur, Taasjir ;
Jia, Gan Wei ;
Tan, S. Q. Lawrence ;
Weijie, How ;
Yang, Eric Koh Sze ;
Keat, Chin Guan ;
Bhattamishra, Subrat Kumar ;
Kesharwani, Prashant ;
Md, Shadab ;
Molugulu, Nagasekhara ;
Pichika, Mallikarjuna Rao ;
Gorain, Bapi .
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2019, 101 :596-613